Business Context and Reporting Period
This Form 8-K Current Report was filed by LeMaitre Vascular, Inc. on August 26, 2024. The filing addresses Item 5.02 regarding the departure of certain officers and the appointment of certain officers.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance changes rather than financial performance data.
Material Changes
- Executive Departure: Joseph P. Pellegrino, Jr. will retire as an employee and Chief Financial Officer effective March 7, 2025, following the anticipated filing of the 2024 Fiscal Year 10-K.
- Board Retention: Mr. Pellegrino will remain on the Board of Directors, having been re-elected in June 2024, and will serve until June 2027.
- Succession Plan: The Company will conduct a search for a replacement CFO, with Mr. Pellegrino expected to assist in the hiring, selection, and onboarding process.
Guidance, Outlook, and Risks
As of August 26, 2024, the Company reaffirmed its financial guidance for Q3 2024 and Full-Year 2024, which was originally issued on August 1, 2024. The filing includes a standard disclaimer regarding forward-looking statements, noting that actual results may differ due to risks and uncertainties detailed in the Company's most recent Form 10-K.
Investor Verification Checklist
- Verify the exact effective date of the CFO transition (March 7, 2025) and the interim leadership structure.
- Review the August 1, 2024 financial guidance reaffirmed in this filing to ensure alignment with current market conditions.
- Monitor upcoming announcements regarding the selection of the new Chief Financial Officer.
- Confirm the timeline for the 2024 Fiscal Year 10-K filing, which triggers the CFO retirement.